Progress Report on Camp Lejeune Settlement Payouts
Overview of Settlement Entities: Within the government, both the Torts Branch and the DOJ are responsible for extending settlement offers to affected individuals.
Torts Branch Settlements:
- Qualified Cases: 50
- Elective Option (EO) Eligible Cases:
- Bladder Cancer: 14
- Kidney Cancer: 12
- non-Hodgkin’s Lymphoma: 10
- Kidney Disease: 5
- Parkinson’s Disease: 4
- Leukemia: 3
- Multiple Myeloma: 2
- Settlement Offers:
- Accepted: 18
- Declined: 9
- Expired: 10
- Pending: 13
- Accepted Settlement Amounts:
- Bladder Cancer: $150,000 – $450,000
- Kidney Disease: $100,000 – $250,000
- Kidney Cancer: $150,000 – $300,000
- non-Hodgkin’s Lymphoma: $150,000
- Multiple Myeloma: $250,000
- Parkinson’s Disease: $100,000 – $400,000
DOJ Settlements:
- Total Cases: 59
- Settlement Offers:
- Accepted: 24
- Rejected: 2
- Expired: 25
- Pending: 8
- Disbursed Payments:
- Total: $3.6 million
- Covered Conditions: Bladder Cancer, Leukemia, non-Hodgkin’s Lymphoma, Parkinson’s Disease, Kidney Cancer, Kidney Disease
- Payment Amounts: $100,000 – $400,000
Evaluating the Progress: While a fraction of cases have been settled, it’s too early to deem the Elective Option a failure. Efforts are underway to expedite the resolution process, including the development of a questionnaire and a roadmap. Additionally, the proposal to appoint a Special Settlement Master reflects a growing recognition of the need for swift settlement efforts.
